The intraoperative staging systems in the management of peritoneal surface malignancy

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 228-231

  Portilla, A Gomez ^a   Shigeki, Kusamura ^b   Dario, Baratti ^b   Marcello, Deraco ^b  

^a Hospital San Jose   (Spain)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Peritoneal cancer index; Peritoneal carcinomatosis; Peritoneal surface malignancy; Staging systems

Indexed keywords

CANCER CLASSIFICATION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CONFERENCE PAPER; HUMAN; INCIDENCE; JAPANESE; PRIORITY JOURNAL; TREATMENT PLANNING;

HUMANS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 50849103065     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21068     Document Type: Conference Paper

References (25)

1. Gilly FN, Carry PY, Sayag AC, et al.: Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124-129.
2. Japanese Research Society for Gastric Cancer: Jpn J Surg 1981;11:127-139.
3. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: Principles of management, editors. Boston: Kluwer Academic Publishers 1996:359-374.
4. Witkamp AJ, de Bree E, Kaag MM, et al.: Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001;37:979-984.
5. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from nongynecological malignacies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363.
6. Elias DM, Pocard M: Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. Surg Oncol Clin N Am 2003;12:543-559.
7. Sugarbaker PH: Successful management of microscopic residual disease in large bowel cancer, Cancer Chemother Pharmacol 1999;43(Suppl):S15-S25.
8. Gomez Portilla A, Sugarbaker PH, Chang D; Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognosis features. World J Surg 1999;23:23-29.
9. Zoetmulder FAN, Verwaal V: Hyperthermic intrapoeritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoineal carcinomatosis of colorectal origion (abstract). ASCO Prog Proc 2002;21:147a.
10. Beaujard AC, Glehen O, Caillot JL, et al.: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000;88:2512-2519.
11. Sayag-Beaujard AC, Francois Y, Glehen O, et al.: Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 1999;19:1375-1382.
12. Rey Y, Porcheron J, Talabard JN, et al.: Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia. Ann Chir 2000;125:631-642 French.
13. Hagiwara A, Togawa T, Yamasaki J, et al.: Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications. Hepatogastroenterology 1999;46:1673-1677.
14. Ouchi K, Sugawara T, Ono H, et al.: Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J. Surg Oncol 1998;69:41-44.
15. Fujimoto S, Takahashi M, Mutou T, et al.: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-891.
16. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132.
17. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76.
18. Tentes AAK, Tripsiannis G, Markakidis SK, et al.: Peritoneal cancer index: A prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 2003;29:69-73.
19. Harmon RL, Sugarbaker PH: Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2005;2:3.
20. Sugarbaker PH: Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and Sarcomatosis. Semin Surg Oncol 1998;14:254-261. Review.
21. Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreduction and hyperthermic intra-peritoneal chemotherapy. J. Surg Oncol 2004;85:61-67.
22. Sugarbaker PH: Management of peritoneal surface malignancy: The surgeon's role. Langenbeck's Arch Surg 1999;384:576-587.
23. Loughlin KG, Moore LF: Using Delphi to achieve congruent objectives and activities in a pediatrics department, J. Med Educ 1979;54:101-106.
24. Keeney S, Hasson F, McKenna H: Consulting the oracle: Ten lessons rom using the Delphi technique in nursing research. J. Adv Nurs 2006;53:205-212.
25. http://www.uicc.org. Last access 7/2006.